IA
ODT

IFP Advisors’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

IFP Advisors’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-200
Closed -$1K – 3539
2021
Q3 		$1K Hold
200
– – ﹤0.01% 3206
2021
Q2 		$1K Hold
200
– – ﹤0.01% 2987
2021
Q1 		$1K Buy
+200
New +$3.78K ﹤0.01% 2922

Other funds holding ODT

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return

IFP Advisors's ODT Position: Q4 2021 in Review

IFP Advisors sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q4 2021, closing a stake of 200 shares — an estimated $1K sold.

IFP Advisors first reported a position in ODT in Q1 2021 and held it in 3 quarters. The position peaked at $1K in Q3 2021. 50 funds tracked by Wall St. Rank hold ODT as of Q4 2021.

  • IFP Advisors reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • IFP Advisors sold 200 Odonate Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $1K.
  • IFP Advisors first reported a position in Odonate Therapeutics, Inc. Common Stock in Q1 2021 and held it in 3 quarters.
  • IFP Advisors's Odonate Therapeutics, Inc. Common Stock position peaked at $1K in Q3 2021.
  • 50 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q4 2021.

Based on IFP Advisors's 13F filing for Q4 2021, filed 12 Jan 2022.